3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Melanoma
2
Breast Neoplasms
2
Wilms Tumor
1
Triple Negative Breast Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Sarcoma, Ewing
1
Ovarian Neoplasms
1
Osteosarcoma
1
Neuroblastoma
1
Lymphoma, Non-Hodgkin
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Kidney Neoplasms
1
Hepatoblastoma
1
Endometrial Neoplasms
1
Desmoid Tumors
1
Colorectal Neoplasms
1
Carcinoma, Renal Cell
1
Carcinoma, Non-Small-Cell Lung
1
Carcinoma, Hepatocellular
1
Breast Carcinoma In Situ
1
Interventions
Cyclophosphamide
16
fludarabine
9
Cytarabine
9
venetoclax
8
Mycophenolic Acid
8
Busulfan
7
fludarabine phosphate
6
Whole-Body Irradiation
6
Tacrolimus
5
Daunorubicin
5
Cyclosporine
5
ruxolitinib
4
ponatinib
4
Rituximab
4
Peripheral Blood Stem Cell Transplantation
4
Methotrexate
4
Etoposide
4
blinatumomab
3
asciminib
3
Vincristine
3
Prednisone
3
Mercaptopurine
3
Inotuzumab Ozogamicin
3
Dexamethasone
3
Azacitidine
3
revumenib
2
quizartinib
2
pegfilgrastim
2
nilotinib
2
ibrutinib
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Leukemia
×
Absorptiometry, Photon
×
90 days
×
Clear all
No trials found.